Other
Black Coffee
Black Coffee is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Withdrawn1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
withdrawn133%
completed133%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056
unknownnot_applicable
Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults
NCT04307979
completedphase_1
Coffee Interaction With the Antihypertensive Drug Felodipine
NCT02232269
Clinical Trials (3)
Showing 3 of 3 trials
NCT01707056Not Applicable
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT04307979Not Applicable
Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults
NCT02232269Phase 1
Coffee Interaction With the Antihypertensive Drug Felodipine
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3